‘Case of the Month’ from Oxford University Hospitals, Oxford, UK: ketamine uropathy with metallic stents and obstructing calculus
Journal article
Hamilton‐Baillie A. et al, (2022), BJU International, 129, 582 - 584
Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: TRoMbone trial.
Journal article
Sooriakumaran P. et al, (2021), BJU Int
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.
Journal article
Sjoberg HT. et al, (2021), Br J Cancer, 125, 534 - 546
Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.
Journal article
Rajakumar T. et al, (2021), Future Oncol, 17, 1083 - 1095
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management
Journal article
Ranasinha N. et al, (2021), BJUI Compass, n/a
The multiple effects of aspirin in prostate cancer patients.
Journal article
Joshi SN. et al, (2020), Cancer Treat Res Commun, 26
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.
Journal article
Philippou Y. et al, (2020), Br J Cancer, 123, 1089 - 1100
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.
Journal article
Sathianathen NJ. et al, (2020), Eur Urol, 78, 402 - 414
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Journal article
Hamdy FC. et al, (2020), Health Technol Assess, 24, 1 - 176
Prescribing patterns for medical treatment of suspected prostatic obstruction: A spatiotemporal statistical analysis of Scottish open access data
Journal article
Andreis F. et al, (2020)
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.
Journal article
Cappuccini F. et al, (2020), J Immunother Cancer, 8
Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.
Journal article
Rao SR. et al, (2020), J Mol Diagn, 22, 652 - 669
Harnessing the potential of multimodal radiotherapy in prostate cancer.
Journal article
Philippou Y. et al, (2020), Nat Rev Urol
Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the 'Fry-Turnbull' effect.
Journal article
Lovegrove CE. et al, (2020), BJU Int, 125, 484 - 486
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.
Journal article
Bryant RJ. et al, (2020), BJU Int, 125, 506 - 514
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Journal article
Neal DE. et al, (2020), Eur Urol, 77, 320 - 330
Re: Pembrolizumab for Treatment-refractory Metastatic Castration-resistant Prostate Cancer: Multicohort, Open-label Phase II KEYNOTE-199 Study
Journal article
Philippou Y. et al, (2020), European Urology
VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer
Conference paper
(2019), Journal of Clinical Oncology
Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis.
Journal article
Elwenspoek MMC. et al, (2019), JAMA Netw Open, 2
Testicular cancer in men with undescended testis: Insights from the Thames Valley Testicular Cancer database
Journal article
(2019), Journal of Clinical Urology